Limited Competition for the Continuation of the Assessment, Serial Evaluation and Subsequent Sequelae of Acute Kidney Injury (ASSESS AKI) Study (U01)

Archived

National Institutes of Health

Description

The purpose of this limited competition is to extend the activities of the ASSESS AKI consortium to continue an observational cohort of patients with normal renal function and with chronic kidney disease (CKD) who have had an episode of AKI and appropriate control participants to ascertain a) long-term renal functional outcomes, b) long-term cardiovascular disease outcomes, c) quality of life and cognitive functional outcomes, and d) survival. In addition, the utility of putative biomarkers to predict short and long-term outcomes will be assessed. The extension will insure the statistical power and the significance of the study outcomes. The extension will insure the statistical power and significance of the study outcomes. The ASSESS AKI is comprised of three Participating Clinical Centers (PCCs) and a data Coordinating Center. An additional site was added as an ancillary study in 2010.

Who can apply

  • Others

Contact

NIH OER Webmaster<br/>FBOWebmaster@OD.NIH.GOV<br/>
FBOWebmaster@OD.NIH.GOV

Key dates & funding
  • PostedAug 30, 2012
  • ClosesNov 21, 2012
  • Program funding$2,200,000
  • CFDA93.847

Pro insight

Edit and export this grant’s proposal template, plus deadline reminders, similar-grant suggestions, and funder history — all available with Pro.

Unlock with Pro